Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06151405
Other study ID # PBRC 2022-001 B
Secondary ID 1K01HL169491-01
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date March 1, 2027

Study information

Verified date June 2024
Source Pennington Biomedical Research Center
Contact Jacob T Mey, PhD, RD
Phone 225-763-2644
Email jacob.mey@pbrc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Determine to what extent three distinct dietary approaches improve asthma control and lung function.


Description:

This is a crossover design pilot trial that will recruit 15 adults with asthma. Participants will undergo screening and a lead-in period before being randomized to a series of three, 7-day diets with a 7+ day washout period between each diet. Asthma control and lung function will be assessed at the completion of each diet. The goal of this pilot trial is to understand the effect of diet on asthma and conduct an exploratory analysis on factors that may predict the response to diet.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date March 1, 2027
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age: 18-65 years - BMI: 18.5 - 29.99 kg/m2 - asthma diagnosed by medical specialist (confirmed in medical history) - partly controlled or uncontrolled asthma by Asthma Control Test score =22 - owns a device compatible with ZEPHYRx platform - stable asthma medication use (no change in the past 2 months). Exclusion Criteria: - Diabetes or using diabetes medications that may lower blood glucose levels - point of care fasting blood glucose =126 mg/dl or triglycerides =400 mg/dl - current smoking or smoking history of greater than 10 pack-years - other significant respiratory or cardiac disease or the presence of clinically important comorbidities, e.g., COPD, renal failure, liver disease; uncontrolled hypertension defined as systolic blood pressure =160 mm/Hg, or diastolic blood pressure =100 mm/Hg - pregnant or nursing women - food preferences or allergies inconsistent with study diet capabilities - noncompliance with lead-in period requirements.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
DGA Diet
A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA) Including: A variety of vegetables and fruits Grains, at least half of which are whole grains Fat-free or low-fat dairy A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.
MCT Diet
A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).
KETO Diet
A fully provisioned isocaloric, isonitrogenous ketogenic study diet.

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (2)

Lead Sponsor Collaborator
Pennington Biomedical Research Center National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other indirect calorimetry nutrient utilization according to respiratory exchange ratio (0.66 - 1.0) baseline, after 7 days on Diet#1, after 7 days on Diet#2, after 7 days on Diet#3
Other ketosis plasma ß-hydroxybutyrate (mM) baseline, after 7 days on Diet#1, after 7 days on Diet#2, after 7 days on Diet#3
Other eosinophilic asthma characterization absolute blood eosinophils (count) baseline, after 7 days on Diet#1, after 7 days on Diet#2, after 7 days on Diet#3
Other immunoglobulin asthma characterization blood immunoglobulin E (IgE) baseline, after 7 days on Diet#1, after 7 days on Diet#2, after 7 days on Diet#3
Other systemic inflammation blood cytokines (IL17, TNFa, IL1ß) baseline, after 7 days on Diet#1, after 7 days on Diet#2, after 7 days on Diet#3
Primary Asthma Control Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5. Baseline
Primary Asthma Control Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5. After 7 days on Diet#1
Primary Asthma Control Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5. After 7 days on Diet#2
Primary Asthma Control Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5. After 7 days on Diet#3
Primary Lung Function FEV1 (forced expiratory volume in 1 second; % of predicted) Baseline
Primary Lung Function FEV1 (forced expiratory volume in 1 second; % of predicted) After 7 days on Diet#1
Primary Lung Function FEV1 (forced expiratory volume in 1 second; % of predicted) After 7 days on Diet#2
Primary Lung Function FEV1 (forced expiratory volume in 1 second; % of predicted) After 7 days on Diet#3
Secondary Systemic inflammation plasma interleukin-6 (IL6) Baseline
Secondary Systemic inflammation plasma interleukin-6 (IL6) After 7 days on Diet#1
Secondary Systemic inflammation plasma interleukin-6 (IL6) After 7 days on Diet#2
Secondary Systemic inflammation plasma interleukin-6 (IL6) After 7 days on Diet#3
Secondary FENO FENO (ppm) Baseline
Secondary FENO FENO (ppm) After 7 days on Diet#1
Secondary FENO FENO (ppm) After 7 days on Diet#2
Secondary FENO FENO (ppm) After 7 days on Diet#3
Secondary FEV1/FVC FEV1/Forced Vital Capacity (FVC) ratio Baseline
Secondary FEV1/FVC FEV1/Forced Vital Capacity (FVC) ratio After 7 days on Diet#1
Secondary FEV1/FVC FEV1/Forced Vital Capacity (FVC) ratio After 7 days on Diet#2
Secondary FEV1/FVC FEV1/Forced Vital Capacity (FVC) ratio After 7 days on Diet#3
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device